PPARG and colitis: Moreover, PGJ2 weakens the inhibition of advanced glycation end products (AGEs) on Treg function [8], and adoptive transfer of PPARγ-deficient Treg cells has a significantly weaker effect than wild-type cells on the prevention and treatment of colitis in SCID mice [9].